Oxford Biomedica Plc (OXBL)

315.75p
   
  • Change Today:
      12.75p
  • 52 Week High: 444.50
  • 52 Week Low: 235.50
  • Currency: UK Pounds
  • Volume: 347

OXBL Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -30.6%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 43.8%
PBT n/a
EPS n/a
DPS n/a

OXBL Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 53.9 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%

OXBL Company Announcements

No recent information was found.

OXBL ShareCast News

No recent information was found.

Latest OXBL Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

OXBL Market Data

Currency UK Pounds
Share Price 315.75p
Change Today 12.75p
% Change 4.21 %
52 Week High 444.50
52 Week Low 235.50
Volume 347

Trades for 23-May-2025

Time Volume / Share Price
08:47 151 @ 306.50p
08:26 51 @ 310.00p
08:23 145 @ 308.00p

OXBL Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page